| Enhanced Protective Efficacy of Nonpathogenic Recombinant Leishmania tarentolae Expressing Cysteine Proteinases Combined with a Sand Fly Salivary Antigen F Zahedifard, E Gholami, T Taheri, Y Taslimi, F Doustdari, N Seyed, ... PLoS neglected tropical diseases 8 (3), e2751, 2014 | 80 | 2014 |
| Cationic solid lipid nanoparticles loaded by cysteine proteinase genes as a novel anti-leishmaniasis DNA vaccine delivery system: characterization and in vitro evaluations. D Doroud, A Vatanara, F Zahedifard, E Gholami, R Vahabpour, ... Journal of Pharmacy and Pharmaceutical Sciences 13 (3), 320-335, 2010 | 74 | 2010 |
| In Silico Analysis of Six Known Leishmania major Antigens and In Vitro Evaluation of Specific Epitopes Eliciting HLA-A2 Restricted CD8 T Cell Response N Seyed, F Zahedifard, S Safaiyan, E Gholami, F Doustdari, ... Plos neglected tropical diseases 5 (9), e1295, 2011 | 72 | 2011 |
| Leishmania major heat shock protein 70 (HSP70) is not protective in murine models of cutaneous leishmaniasis and stimulates strong humoral responses in cutaneous and visceral … S Rafati, E Gholami, N Hassani, F Ghaemimanesh, Y Taslimi, T Taheri, ... Vaccine 25 (21), 4159-4169, 2007 | 70 | 2007 |
| Arginase activity in pathogenic and non-pathogenic species of Leishmania parasites A Badirzadeh, T Taheri, Y Taslimi, Z Abdossamadi, M Heidari-Kharaji, ... PLoS neglected tropical diseases 11 (7), e0005774, 2017 | 58 | 2017 |
| Human neutrophil peptide-1 (HNP-1): a new anti-leishmanial drug candidate S Dabirian, Y Taslimi, F Zahedifard, E Gholami, F Doustdari, ... PLOS Neglected Tropical Diseases 7 (10), e2491, 2013 | 57 | 2013 |
| Leishmania tarentolae secreting the sand fly salivary antigen PpSP15 confers protection against Leishmania major infection in a susceptible BALB/c mice model A Katebi, E Gholami, T Taheri, F Zahedifard, S Habibzadeh, Y Taslimi, ... Molecular immunology 67 (2), 501-511, 2015 | 53 | 2015 |
| Evaluation of DNA/DNA and prime-boost vaccination using LPG3 against Leishmania major infection in susceptible BALB/c mice and its antigenic properties in human leishmaniasis N Abdian, E Gholami, F Zahedifard, N Safaee, S Rafati Experimental parasitology 127 (3), 627-636, 2011 | 50 | 2011 |
| Vaccination with recombinant L7/L12-truncated Omp31 protein induces protection against Brucella infection in BALB/c mice M Golshani, S Rafati, A Dashti, E Gholami, SD Siadat, M Oloomi, A Jafari, ... Molecular immunology 65 (2), 287-292, 2015 | 33 | 2015 |
| Leishmania major: disruption of signal peptidase type I and its consequences on survival, growth and infectivity T Taheri, AH Salmanian, E Gholami, F Doustdari, F Zahedifard, S Rafati Experimental parasitology 126 (2), 135-145, 2010 | 22 | 2010 |
| Live Leishmania tarentolae Secreting HNP1 as an Immunotherapeutic Tool Against Leishmania Infection in BALB/c Mice Z Abdossamadi, T Taheri, N Seyed, H Montakhab-Yeganeh, F Zahedifard, ... Immunotherapy 9 (13), 1089-1102, 2017 | 21 | 2017 |
| DNA plasmid coding for Phlebotomus sergenti salivary protein PsSP9, a member of the SP15 family of proteins, protects against Leishmania tropica E Gholami, F Oliveira, T Taheri, N Seyed, S Gharibzadeh, N Gholami, ... PLoS neglected tropical diseases 13 (1), e0007067, 2019 | 20 | 2019 |
| Delivery systems for Leishmania vaccine development E Gholami, F Zahedifard, S Rafati Expert review of vaccines 15 (7), 879-895, 2016 | 18 | 2016 |
| Leishmania major: Protective capacity of DNA vaccine using amastin fused to HSV-1 VP22 and EGFP in BALB/c mice model A Bolhassani, E Gholami, F Zahedifard, N Moradin, P Parsi, F Doustdari, ... Experimental parasitology 128 (1), 9-17, 2011 | 17 | 2011 |
| Antileishmanial effect of rapamycin as an alternative approach to control Leishmania tropica infection F Khadir, T Taheri, S Habibzadeh, F Zahedifard, E Gholami, ... Veterinary parasitology 276, 108976, 2019 | 11 | 2019 |
| EGFP reporter protein: its immunogenicity in Leishmania-infected BALB/c mice S Seif, F Kazemi, E Gholami, N Seyed, Y Taslimi, S Habibzadeh, ... Applied microbiology and biotechnology 100, 3923-3934, 2016 | 9 | 2016 |
| Nano-adjuvant based on silk fibroin for the delivery of recombinant hepatitis B surface antigen F Rezaei, H Keshvari, MA Shokrgozar, D Doroud, E Gholami, A Khabiri, ... Biomaterials Science 9 (7), 2679-2695, 2021 | 7 | 2021 |
| Expressional comparison between episomal and stable transfection of a selected tri-fusion protein in Leishmania tarentolae T Taheri, E Gholami, F Saatchi, N Seyed, Y Taslimi, S Rafati Vaccine Research 1 (1), 1-9, 2014 | 7 | 2014 |
| Leishmania tarentolae as Potential Live Vaccine Co-Expressing Distinct Salivary Gland Proteins Against Experimental Cutaneous Leishmaniasis in BALB/c Mice … MS Lajevardi, E Gholami, T Taheri, H Sarvnaz, S Habibzadeh, N Seyed, ... Frontiers in Immunology 13, 895234, 2022 | 6 | 2022 |
| The outcome of arginase activity inhibition in BALB/c mice hosting Leishmania tropica S Nahidi, E Gholami, Y Taslimi, S Habibzadeh, N Seyed, E Davarpanah, ... Parasite Immunology 42 (3), e12691, 2020 | 6 | 2020 |
Sima RafatiPasteur Institute of Iran在 pasteur.ac.ir 的电子邮件经过验证
